25023-94-3

Basic information

• Product Name: D-Galactose,O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-
• Synonyms: Galactose,O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-, D- (8CI); Neoagarooctaose
• CAS NO: 25023-94-3
• Molecular Formula: C48H74 O37
• Molecular Weight: 1243.08
• Mol File: 25023-94-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: D-Galactose,O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-(CAS DataBase Reference)
• NIST Chemistry Reference: D-Galactose,O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-(25023-94-3)
• EPA Substance Registry System: D-Galactose,O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-3,6-anhydro-a-L-galactopyranosyl-(1®3)-(25023-94-3)

Safety Data

• Hazardous Substances Data: 25023-94-3(Hazardous Substances Data)

Usage

Uses

Used in Cosmeceuticals:
D-Galactose,O-3,6-anhydro-a-L-galactopyranosyl-(1→3)-O-b-D-galactopyranosyl-(1→4)-O-3,6-anhydro-a-L-galactopyranosyl-(1→3)-O-b-D-galactopyranosyl-(1→4)-O-3,6-anhydro-a-L-galactopyranosyl-(1→3)-O-b-D-galactopyranosyl-(1→4)-O-3,6-anhydro-a-L-galactopyranosyl-(1→3)is used as an active ingredient in cosmeceuticals for its potential benefits in the development of novel skincare products.
Used in Pharmaceutical Research:
This complex carbohydrate structure is also used in pharmaceutical research for its potential therapeutic applications, as it is a part of neoagarooctaose, which may have bioactive properties that can be harnessed for the development of new drugs or therapies.
Used in Biomedical Applications:
The unique structure of D-Galactose,O-3,6-anhydro-a-L-galactopyranosyl-(1→3)-O-b-D-galactopyranosyl-(1→4)-O-3,6-anhydro-a-L-galactopyranosyl-(1→3)-O-b-D-galactopyranosyl-(1→4)-O-3,6-anhydro-a-L-galactopyranosyl-(1→3)-O-b-D-galactopyranosyl-(1→4)-O-3,6-anhydro-a-L-galactopyranosyl-(1→3)may have potential applications in the biomedical field, particularly in the development of biomaterials and drug delivery systems.
Used in Food Industry:
As a component of agarose, this complex carbohydrate structure may also find applications in the food industry, where agarose is used as a gelling agent, thickener, and stabilizer in various food products.

Relevant articles and documents

Overexpression and characterization of a novel thermostable β-agarase YM01-3, from marine bacterium Catenovulum agarivorans YM01T

Genome sequencing of Catenovulum agarivorans YM01T reveals 15 open-reading frames (ORFs) encoding various agarases. In this study, extracellular proteins of YM01T were precipitated by ammonium sulfate and separated by one-dimensional gel electrophoresis. The results of in-gel agarase activity assay and mass spectrometry analysis revealed that the protein, YM01-3, was an agarase with the most evident agarolytic activity. Agarase YM01-3, encoded by the YM01-3 gene, consisted of 420 amino acids with a calculated molecular mass of 46.9 kDa and contained a glycoside hydrolase family 16 β-agarase module followed by a RICIN superfamily in the C-terminal region. The YM01-3 gene was cloned and expressed in Escherichia coli. The recombinant agarase, YM01-3, showed optimum activity at pH 6.0 and 60°C and had a Km of 3.78 mg mL-1 for agarose and a Vmax of 1.14 × 104 U mg-1. YM01-3 hydrolyzed the β-1,4-glycosidic linkages of agarose, yielding neoagarotetraose and neoagarohexaose as the main products. Notably, YM01-3 was stable below 50°C and retained 13% activity after incubation at 80°C for 1 h, characteristics much different from other agarases. The present study highlights a thermostable agarase with great potential application value in industrial production.

Substrate recognition and hydrolysis by a family 50 exo-β-agarase, aga50D, from the marine bacterium Saccharophagus degradans

Background: The catalytic mechanism and substrate recognition required for exo-β-agarase activity are unclear. Results: Structural analysis of a family 50 glycoside hydrolase details substrate recognition and supports a retaining mechanism. Conclusion: The active site architecture dictates exo-activity, whereas substrate distortion aids glycosidic bond hydrolysis. Significance: This structural work offers the first snapshots of Michaelis complexes formed during hydrolysis of the β-linkages in agarose.